tirzepatide injection angle Rotation Map How to Use Mounjaro: Injection

GLP-1 receptor agonist discontinuation among patients with obesity and/or type 2 diabetes

Toss out any frozen pens or vials and get new ones

Table 1 Recent studies investigating GLP analogs and DPP-iv inhibitors use in inflammatory bowel disease

Studies have shown that people who stop using a GLP-1 often regain lost pounds, an issue many contend with as prohibitively expensive name-brand medications continue to dominate a market without mainstream generic alternatives or widespread insurance coverage

Tirzepatide begins at 2.5 mg, which is increased every four weeks to a maximum of 15 mg

It is primarily metabolized via glucuronidation and mitochondrial beta-oxidation, usually with a minor contribution from CYP2C9 and CYP2C19